800-845-6913
Tuteur & Associates, LLC | Knowledge is Power.
February 17, 2008
SUNDAY FEB 17, 2008 (Foodconsumer.org) — A medical researcher said during an interview by CBS Television’s 60 Minutes program scheduled to be aired next Sunday that 22,000 patients would not have died if U.S. regulators acted quicker to remove a Bayer AG drug indicated for use to stem bleeding during open heart surgery, Reuters reported Feb 14.
The drug of concern Trasylol was withdrawn in November at the request by the FDA after the agency learned of an observational study showing the medicine was linked to kidney failure requiring dialysis and increased risk of death in those patients.
At a time over the past many years, the drug was given to as many as a third of all heart bypass patients in the United States.
Dr. Dennis Mangano, the study’s author, said during the interview he first published a study in January 2006 that linked use of Trasylol with increased death risk and 22,000 lives could have been saved if the medicine was recalled after publishing of his study.
Continue reading, ‘Delayed Bayer Drug Trasylol Recall Blamed for 22,000 Deaths.’